250,000 whole genomes sequenced for AGD initiative to advance drug discovery

DNA

Vanderbilt University Medical Center Mar 21 2025 Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc. today announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. Insights from the AGD database are being leveraged to accelerate drug target discovery, therapeutic research and clinical development.

Tag-uri: DNA

din zilele anterioare